India is key for global access to a COVID-19 vaccine – here’s why

India is key for global access to a COVID-19 vaccine – here’s why

This article by Rory Horner, Senior Lecturer, Global Development Institute, University of Manchester, was originally published in The Conversation

Pharmaceutical companies around the world are racing to develop a vaccine. Meanwhile governments scramble to get priority access to the most promising candidates. But a richest-takes-all approach in the fight against the deadliest pandemic in living memory is bound to be counter productive, especially for the recovery of low and middle income countries. The ideal global distribution of a successful COVID-19 vaccine would look beyond which countries have the deepest pockets and instead prioritise health workers, followed by countries with major outbreaks and then those people who are particularly at risk. If governments cannot come together to agree a global strategy, then the global south may need to pin its hopes on the manufacturing might of India.  India has the potential to play a key role in overcoming vaccine nationalism because it is the major supplier of medicines to the global south. Médecins Sans Frontières once dubbed the country the “pharmacy of the world”. India also has, by far, the largest capacity to produce COVID-19 vaccines. Read more here

 

 

Leave a comment

Your email address will not be published. Required fields are marked *